Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) Kinase

Author:

Harris Philip A.ORCID,Faucher Nicolas1,George Nicolas1,Eidam Patrick M.,King Bryan W.,White Gemma V.2,Anderson Niall A.2ORCID,Bandyopadhyay Deepak,Beal Allison M.,Beneton Veronique1,Berger Scott B.,Campobasso Nino,Campos Sebastien2,Capriotti Carol A.,Cox Julie A.,Daugan Alain1,Donche Frederic1,Fouchet Marie-Hélène1,Finger Joshua N.,Geddes Brad,Gough Peter J.,Grondin Pascal1,Hoffman Bonnie L.,Hoffman Sandra J.,Hutchinson Susan E.2,Jeong Jae U.,Jigorel Emilie1,Lamoureux Pauline1,Leister Lara K.,Lich John D.,Mahajan Mukesh K.,Meslamani JamelORCID,Mosley Julie E.2,Nagilla Rakesh,Nassau Pamela M.2,Ng Sze-Ling,Ouellette Michael T.,Pasikanti Kishore K.,Potvain Florent1,Reilly Michael A.,Rivera Elizabeth J.,Sautet Stéphane1,Schaeffer Michelle C.,Sehon Clark A.,Sun Helen,Thorpe James H.2,Totoritis Rachel D.,Ward Paris,Wellaway Natalie2,Wisnoski David D.,Woolven James M.2,Bertin John,Marquis Robert W.

Affiliation:

1. Flexible Discovery Unit, GlaxoSmithKline, 25-27 avenue du Québec, 91951 Les Ulis Cedex, France

2. Flexible Discovery Unit, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3